Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

The pharmaceutical industry has long been reliant on rigorous research and development processes ... By streamlining the initial stages of drug discovery, AI enables researchers to focus their ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Modern pharmaceutical research is undergoing ... methodologies have been extensively applied across various stages of drug development, enhancing research and development efficiency and expediting ...

In its annual 'Measuring the Return from Pharmaceutical Innovation' report based on the top 20 pharma companies by 2020 R&D ...

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

The return on investment in pharma research and development (R&D) has increased from the previous year, with GLP-1 drugs ...